Larvol Delta - Phase-2b-Study-of-Efficacy-and-Safety-of-ASLAN004-in-Adults-With-ModeratetoSevere-Atopic-Dermatitis

ASLAN004 - ASLAN Pharma

http://clinicaltrials.gov/ct2/show/NCT05158023

Dec 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next